NCT01169311
Completed
Not Applicable
A Prospective, Multi-Center Investigation Of The Safety And Performance Of The Covidien EEA™ Hemorrhoid And Prolapse Stapling Set With DST Series™ Technology Im A Hemorrhoidopexy Procedure
ConditionsHemorrhoid
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Hemorrhoid
- Sponsor
- Medtronic - MITG
- Enrollment
- 27
- Locations
- 1
- Primary Endpoint
- Uneventful Creation of a Functional Staple Line at First Firing of Device
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
Trial Objectives
The primary objectives of this clinical trial are to estimate the Covidien EEA™ Hemorrhoid and Prolapse Stapling Set:
overall performance defined by the successful creation of a normal staple line safety as measured by the 30 day incidence of adverse events.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Able to understand and sign Informed Consent Form
- •The participant must be 18-80 years of age.
- •The participant has (symptomatic) Grade 2-4 Hemorrhoids and is eligible for stapled hemorrhoidopexy.
Exclusion Criteria
- •The procedure is needed as revision hemorrhoid surgery.
- •The participant is pregnant.
- •The participant has an active or a history of infection requiring antibiotics at the intended operative site within thirty (30) days prior to the planned surgery date.
- •The participant is unable or unwilling to comply with the study requirements, follow-up schedule.
- •The participant has a history of drug or alcohol abuse.
- •The participant has a history of venous thrombosis or pulmonary embolism.
- •The participant has a history of coagulopathy.
- •The participant is taking aspirin, anti-coagulation and/or anti platelet therapies (e.g.: Warfarin, Levonox) within the last 7 days prior to the planned surgery date
- •The participant has a history of fecal incontinence.
- •The participant has co-morbidities which, in the opinion of the investigator, will not be appropriate for the study.
Outcomes
Primary Outcomes
Uneventful Creation of a Functional Staple Line at First Firing of Device
Time Frame: about 20 minutes for procedure
Successful creation of staple line at first firing of device during hemorrhoidopexy
Secondary Outcomes
- Intra-Operative Bleeding Requiring Intervention(Day 0 - time of surgery)
- Post Operative Pain(baseline, 30 days post op)
- Time to Return to Normal Activity(30 days post op)
- Length of Stay(Day 0, time of discharge minus time of admission)
- OR Time(Day 0 - Time of stop minus time of start)
- Quality of Life, Physical Component(baseline, 30 days post op)
- Incidence of Stapler Malfunction or Misfires(about 20 minutes for procedure)
- Quality of Life, Mental Component(Baseline, 30 days post op)
Study Sites (1)
Loading locations...
Similar Trials
Not yet recruiting
Not Applicable
Clinical Trial of Ventiflow LP Supporting High-risk Percutaneous Coronary Intervention(PCI)Coronary Artery DiseaseHeart FailureHigh-risk PCINCT06754839Suzhou Hearthill Medical Technology Co.,LTD250
Completed
Not Applicable
Software-delivered CBT-I for Insomnia DisorderInsomnia DisorderNCT05747963Peking University Sixth Hospital236
Recruiting
Phase 2
Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp SystemHeart FailureCardiogenic ShockCongenital Heart DiseaseCardiomyopathiesNCT06080074Stanford University50
Active, not recruiting
Not Applicable
Clinical Utility for Ion Endoluminal SystemPulmonary NoduleLung CancerLung DiseasesNCT03893539Intuitive Surgical365
Completed
Not Applicable
A Stool DNA-based SDC2 Methylation Test for the Early Detection of Colorectal CancerColorectal CancerAdvanced Colorectal NeoplasmAdvanced AdenomasNon-neoplastic PolypsNon-advanced AdenomasNCT05255588Genomictree, Inc.2,358